Literature DB >> 19832858

A case of mucous membrane pemphigoid with IgG antibodies against all the alpha3, beta3 and gamma2 subunits of laminin-332 and BP180 C-terminal domain, associated with pancreatic cancer.

T Demitsu, K Yoneda, E Iida, K Sasaki, N Umemoto, M Kakurai, K Wakatabi, T Yamada, B Ohyama, T Hashimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19832858     DOI： 10.1111/j.1365-2230.2009.03646.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN： 0307-6938            Impact factor:   3.470


× No keyword cloud information.
  5 in total

1.  [Anti-p200/anti-laminin γ1 pemphigoid and BP180 NC16A/4575- positive mucous membrane pemphigoid : late diagnosis in a patient with disease-related loss of vision and multiple previous surgical interventions].

Authors:  K M Kaune; M Kasperkiewicz; D Tams; M Bergmann; M Zutt
Journal:  Hautarzt       Date:  2015-01       Impact factor: 0.751

2.  Mucous Membrane Pemphigoid-Associated Malignancies: Case Series and a Brief Overview of the Literature.

Authors:  Michelangelo La Placa; Riccardo Balestri; Federico Tartari; Andrea Sechi; Francesca Ferrara; Camilla Loi; Annalisa Patrizi; Federico Bardazzi
Journal:  Dermatol Pract Concept       Date:  2019-04-30

3.  Keratinocyte footprint assay discriminates antilaminin-332 pemphigoid from all other forms of pemphigoid diseases.

Authors:  F Giurdanella; A M Nijenhuis; G F H Diercks; M F Jonkman; H H Pas
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

4.  Comparison of Two Diagnostic Assays for Anti-Laminin 332 Mucous Membrane Pemphigoid.

Authors:  Stephanie Goletz; Federica Giurdanella; Maike M Holtsche; Miranda Nijenhuis; Barbara Horvath; Gilles F H Diercks; Detlef Zillikens; Takashi Hashimoto; Enno Schmidt; Hendri H Pas
Journal:  Front Immunol       Date:  2021-11-25       Impact factor: 7.561

5.  The Second Study of Clinical and Immunological Findings in Anti-laminin 332-Type Mucous Membrane Pemphigoid Examined at Kurume University-Diagnosis Criteria Suggested by Summary of 133 Cases.

Authors:  Hua Qian; Yohei Natsuaki; Hiroshi Koga; Tamihiro Kawakami; Chiharu Tateishi; Daisuke Tsuruta; Norito Ishii; Xiaoguang Li; Takashi Hashimoto
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.